|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Sector | Acquiring Party | Transferring Party |
|---|---|---|
| Biopharmaceuticals | Abraxis BioScience, Inc. (NASDAQ:ABBI ) | The US branded anesthetic and analgesic injectable product portfolios of AstraZeneca (NYSE:AZN ) |
| Significantly enhances Abraxis' injectable drug portfolio and on-going commitment to provide multi-source and branded injectables to hospitals more... | ||
| Biopharmaceuticals | Advanced BioHealing, Inc. | The assets of Dermagraft and TransCyte from Smith & Nephew (NYSE: SNN; LSE:SN) |
| Complements Advanced BioHealing's proprietary cell culture and tissue engineering technologies. Terms not more... | ||
| Biopharmaceuticals | Amgen (NASDAQ: AMGN) | Abgenix, Inc. |
| Underscores Amgen's commitment to therapeutic oncology. Deal value -- $2.2b cash plus assumed more... | ||
| Biopharmaceuticals | AstraZeneca PLC (NYSE: AZN) | Cambridge Antibody Technology Group PLC (NASDAQ: CATG) |
| Fortifies AstraZeneca's strategy of acquiring biotech companies to expand its drug portfolio, here with a drug for rheumatoid arthritis and a more... | ||
| Biopharmaceuticals | Avanir Pharmaceuticals (NASDAQ: AVNR) | Alamo Pharmaceuticals, LLC |
| Strategic step toward Avanir becoming an integrated pharmaceutical company with CNS products. Deal price is $29m with milestone payments of up to more... | ||
| Biopharmaceuticals | Biogen Idec (NASDAQ: BIIB) | Conforma Therapeutics Corporation |
| Provides significant opportunities for Biogen to develop drugs for a range of solid tumors using Conforma's antagonists. Deal price -- $150m, more... | ||
| Biopharmaceuticals | China Biopharmaceuticals Holdings, Inc.(OTC Bulletin Board: CHBP ) | RACP Pharmaceutical Holdings Ltd. |
| Further bolsters CBH's production and distribution capabilities in China. Deal price is more... | ||
| Biopharmaceuticals | Emergis Inc. (TSX: EME) | The pharmacy management systems business of FrontLine Solutions Inc. |
| Emergis increases its presence in Ontario and now provides pharmacy management systems to some 2,900 pharmacies, or approximately 40% of all more... | ||
| Biopharmaceuticals | Gilead Sciences, Inc. (NASDAQ: GILD) | Raylo Chemicals Inc. from Degussa AG |
| Strengthens Gilead's production of biopharmaceuticals by acquiring chemical and manufacturing expertise and sourcing. Deal price is more... | ||
| Biopharmaceuticals | Merck & Co., Inc. (NYSE: MRK) | GlycoFi, Inc. |
| Enables Merck to develop novel biologic drugs by adding GlycoFi's scientific expertise. Deal price -- $400m more... | ||
| Biopharmaceuticals | Merck & Co., Inc. (NYSE: MRK) | Abmaxis, Inc. |
| Provides Merck with the opportunity to optimize and discover antibodies. Complements Merck's contemporaneous purchase of GlycoFi. Deal price more... | ||
| Biopharmaceuticals | Millipore Corporation (NYSE: MIL) | Serologicals Corporation (NASDAQ: SERO) |
| Millipore expects to increase sales of Serologicals' products in international markets such as Europe, Asia and Japan. Serlogicals's sales more... | ||
| Biopharmaceuticals | Millipore Corporation (NYSE:MIL) | Newport Bio Systems |
| Enables Millipore to provide a more comprehensive line of disposable process containers, manifolds, and assembly systems for collecting, storing, and more... | ||
| Biopharmaceuticals | Pfizer, Inc.(NYSE: PFE) | Rinat Neuroscience Corporation |
| Enhances Pfizer's internal R&D efforts by adding Rinat's expertise in using protein-based therapeutics to develop new medicines, notably more... | ||
| Data Management/ Healthcare IT | 3M Information Systems | SBG GmbH |
| Expands and strengthens 3M's product portfolio in coding, DRG determination and medical documentation. Terms not more... | ||
| Data Management/ Healthcare IT | CareMedic Systems, Inc. | ActaView, LLC |
| Enhances CareMedic's suite of healthcare revenue cycle management solutions. Terms not more... | ||
| Data Management/ Healthcare IT | Cerner Corp. (NASDAQ: CERN) | Galt Associates, Inc. |
| Augments Cerner's LifeSciences portfolio, adding innovative solutions that use medical event data to monitor and manage the safety and efficacy more... | ||
| Data Management/ Healthcare IT | HCPRO, INC. | HRAI Coding Specialists, LLC |
| After completing six acquisitions in 2005, the HRAI deal is HCPro's third acquisition of 2006. Here, it further expands into the medical coding, more... | ||
| Data Management/ Healthcare IT | McKesson Corporation (NYSE:MCK) | RelayHealth Corporation |
| Provides a fundamental building block in McKesson's physician connectivity strategy as well as consumer and personal health management more... | ||
| Data Management/ Healthcare IT | MedAssist, Incorporated | Capstone Solutions, LLC |
| Complements MedAssist's core software lines while adding several new solutions: business office operational assessments, process improvement more... | ||
| Data Management/ Healthcare IT | Spheris, Inc. | Vianeta Communications |
| Integrating Vianeta's open and scalable XML-based software into Spheris' existing transcription technology accelerates Spheris' document more... | ||
| Data Management/ Healthcare IT | TotalMed Inc. (OTC: TTMD) | eNotes Systems, Inc. |
| Allows TotalMed to offer a suite of clinical and administrative tools, including a leading electronic medical records system, a staffing solutions more... | ||
| Data Management/ Healthcare IT | WebMD Health Corp (Nasdaq:WBMD) | Summex |
| Further strengthens WebMD's offerings to change high-risk behaviors that lead to illness and high medical costs. Deal price -- $30m cash, plus more... | ||
| Dental | Danaher Corporation (NYSE: DHR) | Sybron Dental Specialties Inc. (NYSE: SYD) |
| Sybron’s consumables and small equipment offerings are a logical extension of Danaher’s existing dental equipment portfolio. Deal value - more... | ||
| Dental | Sybron Dental Specialties, Inc.(NYSE:SYD) | Dental Disposables International, Inc. |
| Strengthens Sybron's infection prevention more... | ||
| Diagnostics | Agilent Technologies, Inc. (NYSE: A) | SynPro Corporation |
| Enables Agilent to offer an array of value-added services including development of analytical methods, stability studies, and regulatory support. more... | ||
| Diagnostics | AmeriPath, Inc. | Rose Pathology Associates, P.C. |
| Enhances AmeriPath's pathology services to both hospital and outpatient practices in the Denver market. Terms not more... | ||
| Diagnostics | Haemonetics Corporation (NYSE: HAE ) | Arryx, Inc. |
| Nano-separation technology adds to Haemonetics' blood separation competency. Deal price is $26m for shares Haemonetics does not already more... | ||
| Diagnostics | Hologic, Inc. (NASDAQ: HOLX) | AEG Elektrofotografie GmbH |
| AEG is Hologic’s sole supplier of coatings employed in its Selenia digital mammography detectors, permitting Hologic to more efficiently manage more... | ||
| Diagnostics | IRIS International, Inc. (NASDAQ:IRIS) | Leucadia Technologies, Inc. |
| Strengthens IRIS' strategic position and significantly broadens its product portfolio by adding a molecular diagnostics platform. Deal price is more... | ||
| Diagnostics | Molecular Devices Corporation (NASDAQ: MDCC) | The Laser Capture Microdissection-related business of Arcturus Bioscience |
| Expands Molecular Devices' life sciences portfolio by adding enabling tools for cellular analysis. Deal price is $10m more... | ||
| Diagnostics | Nanogen, Inc. (Nasdaq: NGEN ) | Amplimedical S.p.A. diagnostics division |
| Expands Nanogen's molecular diagnostic business in Europe. Deal value - more... | ||
| Diagnostics | OTN | The Oncology Distribution business of Cardinal Health (NYSE: CAH) |
| Increases OTN's customers to more than 4,000 specialty practices nationwide, including oncology and rheumatology practices, and broadens its more... | ||
| Diagnostics | PerkinElmer, Inc. (NYSE: PKI) | Clinical & Analytical Service Solutions, Ltd. |
| Strengthens PerkinElmer's ability to meet the $2.5b laboratory equipment aftermarket. Target business enhances lab productivity, reduces costs more... | ||
| Diagnostics | Solos Endoscopy, Inc. (Other OTC:SLSE.PK ) | The early cancer detection product line from Lifeline Biotechnologies, Inc. (OTC:LBTN.PK ) |
| Provides Solos with a complementary line of diagnostic products specific to early cancer detection. Deal price is $4m in restricted shares of more... | ||
| Diagnostics | Trinity Biotech plc. (NASDAQ NM: TRIB) | The coagulation product line from bioMerieux. |
| Following the merger, it is estimated that Trinity's share of the $600m worldwide coagulation market will be 13%. The target lines can be sold more... | ||
| Distribution | Henry Schein, Inc. (Nasdaq: HSIC) | Three Darby Group businesses: Island Dental Co., Inc., Darby Medical Supply Co. and Darby Dental Laboratory Supply Co., Inc. |
| Extends Henry Schein's reach into dental and medical markets, offering new products, services and programs. Deal price for the 3 Darby more... | ||
| Distribution | Henry Schein, Inc. (Nasdaq: HSIC) Henry Schein, Inc. (Nasdaq: HSIC) | NLS Animal Health |
| Expands Schein's veterinary footprint in the US, and, along with its growing European veterinary presence, offers sales channels internationally. more... | ||
| Distribution | Midwest Medical Supply, Inc. | The Caligor Hospital Supply and Extended Care business of Henry Schein, Inc. |
| Gives MMS a strong presence in the northeast and continues its goal to have a national distribution presence. More than doubles MMS' sales to more... | ||
| Distribution | Welch Allyn | MediAids |
| Expands Welch Allyn's reach in SE Asia. Terms not more... | ||
| Medical Devices | Abbott Laboratories (NYSE: ABT) | The vascular intervention and endovascular solutions business units of Guidant (NYSE: GDT) |
| Guidant's vascular business offers a broad line of leading coronary and endovascular products, an effective sales force, global manufacturing more... | ||
| Medical Devices | American Medical Systems Holdings Inc.(NASDAQ:AMMD ) | Laserscope (NASDAQ:LSCP) |
| Strengthens AMS' strong reputation in urological products with a range of therapy solutions for BPH patients. The use of laser-based technologies more... | ||
| Medical Devices | American Medical Systems Holdings, Inc. (NASDAQ:AMMD) | Assets of BioControl Medical, Ltd. |
| Combines BioControl's implantation technology with American's presence in the urology and gynecological markets to broaden the application of more... | ||
| Medical Devices | Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) | Quill Medical, Inc. |
| Expands Angiotech's offerings in the aesthetic surgery and wound closures markets. Product line enables plastic surgeons and dermatologists to more... | ||
| Medical Devices | Boston Scientific (NYSE: BSX) | Guidant (NYSE: GDT) |
| Outbidding J&J, BSX fortifies itself as a global leader in cardiovascular devices. Boston Scientific has also completed an agreement with Abbott more... | ||
| Medical Devices | C. R. Bard, Inc. (NYSE:BCR) | Venetec International, Inc |
| With this $166m acquisition, Bard Medical adds a leading complementary line of catheter securement devices, used primarily in acute care facilities, more... | ||
| Medical Devices | Cardinal Health, Inc. (NYSE: CAH) | Denver Biomedical, Inc |
| Enhances Cardinal's offerings with a specialty drainage product line used for terminally-ill cancer patients. Terms not more... | ||
| Medical Devices | Coloplast A/S | The urology business of Mentor Corporation |
| This bid significantly enlarges the scope of Coloplast's urology business and strengthens its position in Europe and the US. Combined annualized more... | ||
| Medical Devices | Derma Sciences, Inc. (OTCBB: DSCI) | The assets of Western Medical Ltd. |
| Adds a complementary niche high margin wound care product line using the same distributor network and call points. Deal price is $6.5m, with $6.5m more... | ||
| Medical Devices | dj Orthopedics, Inc. (DJO) | Aircast, Inc. |
| Fortifies dj's presence with orthopedic surgeons and other providers by adding Aircast's strong ankle and vascular brands. Expands dj's more... | ||
| Medical Devices | ETHICON, INC. | Vascular Control Systems, Inc. |
| Strengthens Ethicon's gynecology business by adding Vascular's technology for uterine artery occlusion treatment that offers a more... | ||
| Medical Devices | Genzyme Corporation | The Glucan Hernia product lines from Brennen Medical |
| Expands Genzyme's offerings for hernia repair by adding beta glucan impregnated mesh. Terms not more... | ||
| Medical Devices | Integra LifeSciences Holdings Corporation (Nasdaq:IART) | Miltex, Inc. |
| Expands Integra's instrument lines and opens up private physician, dental and ambulatory surgery care channels. Deal price is $101m. more... | ||
| Medical Devices | Integra LifeSciences Holdings Corporation (Nasdaq:IART) | Kinetikos Medical, Inc. |
| Complements Integra's growing extremity business and strengthens its presence in the orthopedic hand market, leveraging regenerative products for more... | ||
| Medical Devices | Kensey Nash Corporation (NASDAQ: KNSY) | IntraLuminal Therapeutics, Inc. |
| Serves as a platform to develop products to meet the clinical needs of the emerging chronic total occlusions (CTO) market. Asset purchase for more... | ||
| Medical Devices | Laserscope (Nasdaq: LSCP ) | InnovaQuartz, Inc. |
| Extends Laserscope's medical disposables product line, enhances its R&D expertise and expands its manufacturing capabilities. Deal vaue - more... | ||
| Medical Devices | Medical Creative Technologies, Inc. | The intellectual property of Dexterity Surgical Inc. |
| Adds Dexterity Protractor® and Dexterity PneumoSleeve® to MCT's minimally invasive surgery product line. Terms not more... | ||
| Medical Devices | MediCor Ltd. (OTC: MDCR) | Biosil Limited and related supplier Nagor Limited |
| Strengthens MediCor's aesthetic and reconstructive lines and European business. Deal price is $36.9m plus MediCor more... | ||
| Medical Devices | Misonix, Inc. (Nasdaq: MSON) | UK-HIFU Limited |
| Enables Misonix to strengthen its presence in the European HIFU market and broaden the acceptance and use of HIFU-based medical devices. Terms not more... | ||
| Medical Devices | Mölnlycke Health Care | Regent Medical and Medlock Medical |
| Significantly enhances product range and geographical expansion for Molnlycke's two divisions, Surgical and Wound Care. Reflects sales force, more... | ||
| Medical Devices | Moog Inc. | Curlin Medical LLC |
| Moog's expertise in the electronic control of fluid-flow metering devices combined with Curlin's reputation in the medical market is expected more... | ||
| Medical Devices | OSI Systems, Inc. (NASDAQ:OSIS) | The DelMar Cardiac Division of Ferraris Group plc |
| DelMar's cardiac monitoring systems can be marketed to hospitals in conjunction with OSI/Spacelabs' core products of patient monitoring more... | ||
| Medical Services | Cardinal Health, Inc. (NYSE: CAH) | The pharmaceutical wholesale distribution business of The F. Dohmen Co. |
| Complements Cardinal's existing suite of services and enhances value proposition to retail pharmacy customers. Terms not more... | ||
| Medical Services | RehabCare Group, Inc. (NYSE: RHB) | Symphony Health Services LLC |
| Expands RehabCare to be one of the largest providers of rehabilitation program management services in the US. Deal price - - more... | ||
| Medical Services | Sentinel Capital Partners | Interim HealthCare, Inc. |
| Expands Sentinel's portfolio with Interim's diverse services including home care, facility medical staffing, occupational health staffing more... | ||
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. | ||